Draig Therapeutics Limited

Psychiatry and Mood Disorders

Draig Therapeutics Limited is involved in clinical research focused on Major Depressive Disorder, with an emphasis on treatment options for depressive symptoms in adults.

  • Depressive symptoms
  • Major Depressive Disorder
  • Adult psychiatry

The sponsor’s research activity is centred on therapeutic development for mood disorders and related psychiatric care.

Neuropsychiatric Therapeutics

The company’s clinical interest includes medicines designed to address neuropsychiatric symptoms associated with depression and improve mental health outcomes.

  • Antidepressant therapies
  • Mental health treatment
  • Symptom relief

Its trial portfolio reflects a focus on therapeutic innovation in central nervous system disorders, particularly conditions affecting emotional regulation and daily functioning.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder

    Recruiting

    Investigated diseases:
    Bulgaria Czechia Poland